5650-52-2Relevant articles and documents
Control of the Bandgap of Conducting Polymers by Rigidification of the ?-Conjugated System
Roncali, Jean,Thobie-Gautier, Christine,Elandaloussi, El Hadj,Frere, Pierre
, p. 2249 - 2250 (1994)
Rigidification of E-1,2(2,2'-dithienylethylene) by bridging the thiophene rings with the central double bond leads to a ca. 0.40 eV decrease of the bandgap of the resulting conducting polymer.
SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
-
, (2016/04/10)
Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.
FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS ROR GAMMA MODULATORS
-
Page/Page column 80; 81; 82, (2015/07/16)
The present invention provides fused thiophene and thiazole derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; in which R1, R2, R3, R4, R5, R6, R7, X1, X2, L, m, n and ring A have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorders, in particular their use in disease(s) or disorder(s) where there is an advantage in modulating RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the fused thiophene and thiazole derivatives of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.